News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Erchonia Medical Announces Judge Denies Primcogent's Attempt to Block Erchonia From Continuing to Sell Its Patented Zerona Devices


6/5/2013 10:00:38 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MCKINNEY, Texas--(BUSINESS WIRE)--Erchonia announced today that after hearing 2 days of testimony from witnesses for both Erchonia and Primcogent on Primcogent’s application for temporary restraining against Erchonia seeking to prevent Erchonia from selling its patented and patent-pending devices, the Judge granted Primcogent only very limited relief. The only relief granted to Primcogent was that for the approximately 14 day term of the order, Erchonia may not, without prior permission, contact or solicit Primcogent’s customers or Primcogent’s employees. Erchonia was not otherwise limited from selling its Zerona and Zerona AD devices for the non-invasive circumference reduction of the waist, hips, thighs and arms.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES